Voxx Analytics Announces Release of Voxx.Gateway for Medical Device and Early-Stage Life Science Companies

Share Article

Gateway provides device, diagnostic, and early-stage biopharma companies access to industry-leading data and analytics services

“Our customers need to form earlier and better relationships with customer stakeholders and influencers but some lack the comprehensive analytics they need,” Steve Decker, Director of Business Development for Voxx Analytics, explains. “Gateway is a solution."

Voxx Analytics announces the immediate availability of Voxx.Gateway, an analytics product enabling mid-level and early-stage companies to access the power of influence analytics and data-driven engagement decision making.

“For years we’ve been working to make our solutions available to a broader market that didn’t necessarily have access to the same financial resources as our Top 50 pharma and biotech clients,” said Daniel Vesely, President and COO at Voxx Analytics. “Today we are thrilled to announce Voxx.Gateway as the next step to help customers better understand the markets they seek to engage.”

Award-Winning Impact
In June, Voxx Analytics was named a 2018 Gartner Cool Vendor for its comprehensive analysis of entire disease communities. Many customers, particularly in medical diagnostics, devices and early-stage biopharma companies, have even more focused needs. “Our customers need to form earlier and better relationships with customer stakeholders and influencers but some lack the comprehensive analytics they need,” Steve Decker, Director of Business Development for Voxx Analytics, explains. “Gateway is a solution for teams that struggle with budgets, but still need world class data and analytics.” Voxx.Gateway gives customers a clear view of their market core, including key influencers, and provides a data foundation that can be scaled up as progress and activities increase.

Voxx.Gateway
Voxx.Gateway is the latest offering to demonstrate Voxx Analytics’ commitment to deliver cutting edge data and analytics to the life sciences industry. Voxx Analytics is the worldwide leader in influence analytics for life sciences. The company offers a wide range of products and services designed to help companies in the life sciences engage with their communities better and perform at a higher level.

For more information, press only:
Steve Decker, Director Sales and Business Development
714-489-2015
sdecker(at)voxxanalytics(dot)com
For more information on Voxx.Gateway:
http://www.voxxanalytics.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Anthony Page
Visit website